Skip to main content
Publication date
2016 08 20
Authors
Wentzensen, N Poole, EM Trabert, B White, E Arslan, AA Patel, AV Setiawan, VW Visvanathan, K Weiderpass, E Adami, HO Black, A Bernstein, L Brinton, LA Buring, J Butler, LM Chamosa, S Clendenen, TV Dossus, L Fortner, R Gapstur, SM Gaudet, MM Gram, IT Hartge, P Hoffman-Bolton, J Idahl, A Jones, M Kaaks, R Kirsh, V Koh, WP Lacey, JV Lee, IM Lundin, E Merritt, MA Onland-Moret, NC Peters, U Poynter, JN Rinaldi, S Robien, K Rohan, T Sandler, DP Schairer, C Schouten, LJ Sjoholm, LK Sieri, S Swerdlow, A Tjonneland, A Travis, R Trichopoulou, A van den Brandt, PA Wilkens, L Wolk, A Yang, HP Zeleniuch-Jacquotte, A Tworoger, SS
Author KI Usernames
Adami, HO|hanada Sjoholm, LK|lousjo Sjöholm, LK|lousjo Weiderpass, E|eliwei Wolk, A|aliwol
Pubmed ID
27325851
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Doctype
Article
KI Connection
Låg
Mesh SV
Asien Cystadenokarcinom, seröst Endometrioid karcinom Europa Klarcellsadenokarcinom Kvinnlig Körtel- och epiteltumörer Medelålders personer Mucinöst adenokarcinom Människa Nordamerika Proportional hazard-modeller Riskfaktorer Vuxna Äggstockstumörer
Mesh EN
Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Asia Carcinoma, Endometrioid Carcinoma, Ovarian Epithelial Cystadenocarcinoma, Serous Europe Neoplasms, Glandular and Epithelial North America Ovarian Neoplasms Proportional Hazards Models Risk Factors
First date
2016-09-25T10:57:42.662Z